ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

DERM Journey Medical Corporation

3.69
0.06 (1.65%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Journey Medical Corporation NASDAQ:DERM NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.06 1.65% 3.69 3.52 5.25 3.7299 3.52 3.63 51,784 05:00:06

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

02/03/2020 12:47pm

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-36668

 

 

DERMIRA, INC.

(Exact name of registrant as specified in its charter)

 

 

Lilly Corporate Center

Indianapolis, Indiana 46285

Telephone: (650) 421-7200

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, $0.001 par value per share

(Title of each class of securities covered by this Form)

None

(Title of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

  Rule 12g-4(a)(1)  
  Rule 12g-4(a)(2)  
  Rule 12h-3(b)(1)(i)  
  Rule 12h-3(b)(1)(ii)  
  Rule 15d-6  
  Rule 15d-22(b)  

Approximate number of holders of record as of the certification or notice date: One

Pursuant to the requirements of the Securities Exchange Act of 1934, Dermira, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: March 2, 2020     Dermira, Inc.
    By:  

/s/ Heather Wasserman

    Name:   Heather Wasserman
    Title:   President

 

 

 

1 Year Journey Medical Chart

1 Year Journey Medical Chart

1 Month Journey Medical Chart

1 Month Journey Medical Chart

Your Recent History

Delayed Upgrade Clock